Expert Insight on Using Dual-IO Regimens for Melanoma in Real-World Practice
Panelists discuss how using dual immunotherapy regimens for melanoma in real-world practice involves balancing efficacy with safety, patient comorbidities, and treatment accessibility, while also addressing challenges such as immune-related adverse events and treatment sequencing.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
